Medicines Designed for African Patients Get $1m Boost

In the scientific language of the University of Cape Town's announcement, the project will "focus on addressing the issue of variability in drug response across African populations, which is mostly driven by genetic differences in the expression and activity of drug-metabolising enzymes".



Professor Kelly Chibale, left, who is leading ground-breaking research into new drugs to be developed for African conditions, with scientific officer Jessica Akester at Cape Town's Drug Discovery and Development Centre.

Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.